Study shows benefits of integrated palliative and oncology care for patients with advanced AML
A first-of-its-kind intervention integrating palliative care early in the course of cancer therapy for patients with advanced acute myeloid leukemia (AML), a highly aggressive cancer of the blood and bone marrow, resulted in substantial improvements in patients quality of life, mood and end-of-life care, a team of investigators has found.
We know from the literature that patients with acute myeloid leukemia have high rates of post-traumatic stress disorder.
Areej El-Jawahri, MD, Co-Investigator, Hematologist-Oncologist, Massachusetts General Hospital (MGH) Cancer Center
El-Jawahri and colleagues at Duke University Medical Center in Durham, North Carolina, the University of Pennsylvania in Philadelphia and Ohio State University in Columbus, conducted a randomized clinical trial demonstrating the benefits of early integration of palliative care into oncology care for patients with hi